Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
1.840
-0.340 (-15.60%)
May 18, 2026, 4:00 PM EDT - Market closed
Equillium Employees
Equillium had 35 employees as of December 31, 2024. The number of employees decreased by 9 or -20.45% compared to the previous year.
Employees
35
Change
-9
Growth
-20.45%
Revenue / Employee
n/a
Profits / Employee
-$544,429
Market Cap
116.34M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 35 | -9 | -20.45% |
| Sep 30, 2024 | 45 | 0 | - |
| Jun 30, 2024 | 45 | -2 | -4.26% |
| Mar 31, 2024 | 44 | 7 | 18.92% |
| Dec 31, 2023 | 44 | 8 | 22.22% |
| Sep 30, 2023 | 45 | 0 | - |
| Jun 30, 2023 | 47 | 2 | 4.44% |
| Mar 31, 2023 | 37 | -10 | -21.28% |
| Dec 31, 2022 | 36 | -9 | -20.00% |
| Sep 30, 2022 | 45 | 0 | - |
| Jun 30, 2022 | 45 | - | - |
| Mar 31, 2022 | 47 | 16 | 51.61% |
| Dec 31, 2021 | 45 | 14 | 45.16% |
| Dec 31, 2020 | 31 | 15 | 93.75% |
| Sep 30, 2020 | 26 | 10 | 62.50% |
| Jun 30, 2020 | 22 | 6 | 37.50% |
| Mar 31, 2020 | 22 | 7 | 46.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fractyl Health | 100 |
| enGene Therapeutics | 82 |
| Agenus | 81 |
| Pyxis Oncology | 56 |
| OnKure Therapeutics | 45 |
| Cardiff Oncology | 31 |
| Genelux | 26 |
| Coya Therapeutics | 8 |
EQ News
- 4 days ago - Equillium Slides: Corporate presentation - Filings
- 5 days ago - Equillium reports Q1 EPS (6c), consensus (4c) - TheFly
- 5 days ago - Equillium appoints Snehal Naik as chief development officer - TheFly
- 5 days ago - Equillium Reports First Quarter 2026 Financial Results and Corporate Highlights - GlobeNewsWire
- 5 days ago - Equillium Earnings release: Q1 2026 - Filings
- 5 days ago - Equillium Quarterly report: Q1 2026 - Filings
- 17 days ago - Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 20 days ago - Equiniti (EQ) Launches DealTrax™: A Digital-First Platform for Corporate Actions and M&A Events - GlobeNewsWire